Position in GLSI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,215,677
+$1,161,383 QoQ
Shares Held
133,875
+36.9% QoQ
Ownership
0.912%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 28%
Shared 0%
None 72%
Common Shares in GLSI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,291,958,108 across 423 Biotechnology names. GLSI ranks #217 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in GLSI
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,215,677 | 133,875 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,054,294 | 97,777 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $815,362 | 81,946 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $745,980 | 82,247 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $717,484 | 75,208 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $822,125 | 73,208 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,026,132 | 71,408 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,180,635 | 68,403 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $259,259 | 13,002 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $136,781 | 13,002 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $114,937 | 13,002 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $125,404 | 13,002 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $179,297 | 13,002 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $197,630 | 13,002 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $118,318 | 13,002 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $110,126 | 13,002 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,304,435 | 66,485 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,588,967 | 65,309 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,333,025 | 59,714 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,256,527 | 50,212 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||